Investors looking for profitable pandemic plays have a plethora of biotech firms to choose from. The one that’s the subject of today’s article, however, may not be one of them, despite the fact that some are betting on it as a COVID play. In fact, one market analyst has warned “Investors beware” in regards to this stock. For the stock in question and a look at the concerns surrounding it, CLICK HERE.
